Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
David M. Maahs(Stanford University), John W. Lum(Jaeb Center for Health Research), Eyal Dassau(Midwest Orthopaedic Research Foundation), Steven C. Griffen(Breakthrough T1D), Steven J. Russell(Boston University), Roman Hovorka(Wellcome/MRC Institute of Metabolic Science), Brian Levy(Unknown), Moshe Philip(Tel Aviv University), Ahmad Haidar(McGill University), J. Hans DeVries(University of Cape Town), Éric Renard(Centre National de la Recherche Scientifique), Stuart A. Weinzimer(Yale University), Jessica R. Castle(Oregon Health & Science University), David N. O’Neal(Baker Heart and Diabetes Institute), Bruce A. Buckingham(Stanford University), Howard Zisser(University of California, Santa Barbara), Ali Çınar(Illinois Institute of Technology), Lutz Heinemann(Deutsches Diabetes-Zentrum e.V.), Boris Kovatchev(University of Virginia), Francis J. Doyle(Brown University), Edward R. Damiano(Boston University), Timothy W. Jones(The University of Western Australia), Craig Kollman(Jaeb Center for Health Research), Revital Nimri(Rabin Medical Center)
Cited by 215
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
A rapid DNA isolation procedure for small amounts of fresh leaf tissue
|Medical Entomology and Zoology|1987|2.4k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Dynamic Flux Balance Analysis of Diauxic Growth in Escherichia coli
|Biophysical Journal|2002|962
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
|New England Journal of Medicine|2019|960